quantitative
Analysis v1
Strong Support

People with heart disease who took a drug called evolocumab had more heart-related deaths than those who took a dummy pill, according to a reanalysis of a major study — but the difference wasn’t quite strong enough to rule out chance.

80
Pro
0
Against

Evidence from Studies

Supporting (1)

80

Community contributions welcome

The study looked at the same drug and patients as the claim and found more heart-related deaths in the treatment group, just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.